cyclosporine has been researched along with cilastatin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hammer, C; Modic, PK; Mraz, W | 1 |
| Drechsel, J; Hammer, C; Markewitz, A; Pfeiffer, M; Reichart, B; Reichenspurner, H; Zahn, S | 1 |
| Arduino, RC; Johnson, PC; Miranda, AG | 1 |
| Bernis, C; Fernández-Rañada, JM; Gruss, E; Rodriguez, F; Tomás, JF; Traver, JA | 1 |
| Horstkotte, D; Klein, RM; Kramer, A; Niehues, R; Schaal, KP; Schlüter, S; Strauer, BE | 1 |
| Boggi, U; Carmellini, M; Filipponi, F; Frosini, F; Mosca, F | 1 |
| Boggi, U; Carmellini, M; Cecconi, S; Giampietro, O; Matteucci, E; Mosca, F | 1 |
| Castilla, M; Lázaro, JA; Pérez, M; Sarmiento, E; Tejedor, A; Torres, AM | 1 |
| Caramelo, C; Castilla, M; de Lucas, C; Lazaro, JA; Tejedor, A; Torres, AM | 1 |
1 review(s) available for cyclosporine and cilastatin
| Article | Year |
|---|---|
Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence.
Topics: Acute Kidney Injury; Cilastatin; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipenem; Kidney Function Tests; Male; Probability; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2007 |
4 trial(s) available for cyclosporine and cilastatin
| Article | Year |
|---|---|
Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylglucosaminidase; Adolescent; Adult; Blood Urea Nitrogen; Cilastatin; Creatinine; Cyclosporine; Female; Heart Transplantation; Hemofiltration; Humans; Kidney Diseases; Male; Middle Aged; Single-Blind Method; Thromboxane B2 | 1994 |
Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis.
Topics: Acute Kidney Injury; Adult; Bone Marrow Transplantation; Cilastatin; Cyclosporine; Female; Graft vs Host Disease; Humans; Imipenem; Immunosuppressive Agents; Kidney; Leukemia; Male; Protease Inhibitors; Retrospective Studies; Transplantation, Homologous | 1996 |
Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients.
Topics: Acute Disease; Adult; Cadaver; Cilastatin; Creatinine; Cyclosporine; Female; Graft Survival; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Protease Inhibitors | 1997 |
Imipenem/cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients.
Topics: Acetylglucosaminidase; Albuminuria; Antibiotic Prophylaxis; Ceftazidime; Cilastatin; Creatinine; Cyclosporine; Diuresis; Graft Rejection; Graft Survival; Humans; Imipenem; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Lipoproteins; Protease Inhibitors; Thienamycins | 1998 |
7 other study(ies) available for cyclosporine and cilastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Impact of imipenem/cilastatin on cyclosporine metabolism and excretion.
Topics: Animals; Bile; Cilastatin; Cyclosporine; Cytosol; Imipenem; Ketoconazole; Liver; Male; Phenobarbital; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azathioprine; Case-Control Studies; Cilastatin; Clavulanic Acids; Cyclosporine; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Nocardia; Nocardia asteroides; Nocardia Infections; Prednisone; Prospective Studies; Sulfadiazine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
[Systemic Nocardia asteroides infection with endocardial involvement in a patient undergoing immunosuppressive therapy].
Topics: Anti-Bacterial Agents; Brain Diseases; Cilastatin; Cyclosporine; Doxycycline; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Eye Infections, Bacterial; Fatal Outcome; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia; Protease Inhibitors; Status Epilepticus; Thienamycins | 1996 |
Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells.
Topics: Animals; Apoptosis; Biological Transport; Cell Membrane; Cells, Cultured; Cilastatin; Cyclosporine; Dipeptidases; Dose-Response Relationship, Drug; Epithelial Cells; Immunosuppressive Agents; Kidney Tubules, Proximal; Membrane Fluidity; Membrane Microdomains; Microvilli; Protease Inhibitors; Swine; Swine, Miniature; Tacrolimus | 2004 |